No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
USA — Bayer and Hologic have joined forces with a singular mission: to revolutionize breast cancer scans. Their visionary approach combines Bayer’s cutting-edge imaging contrast agents with Hologic’s state-of-the-art mammography…
Read More
GERMANY — Germany’s pioneering biopharmaceutical company, BioNTech, has embarked on a transformative journey in the realm of infectious disease prevention, partnering with the Coalition for Epidemic Preparedness Innovations (CEPI). This…
Read More
GERMANY —Bayer’s newly appointed CEO, Bill Anderson, is planning a strategic overhaul that begins with trimming down management positions to expedite decision-making in a bold move aimed at rejuvenating the…
Read More
GERMANY — A groundbreaking cell therapy designed to combat Parkinson’s disease has achieved promising results in an early-stage clinical trial, as announced by its developer, Bluerock Therapeutics. The therapy, known…
Read More
GERMANY — Siemens Healthineers, a key player in healthcare technology, is confronting a potential data breach as the LockBit ransomware group alleges an attack on one of its subsidiaries. The…
Read More
GERMANY —In a strategic move poised to reshape the trajectory of its Pharmaceuticals Division, Bayer has named Dr. Juergen Eckhardt as the new Head of Business Development & Licensing /…
Read More
GERMANY — Boehringer Ingelheim, a pioneering pharmaceutical force, is intensifying its pursuit of an obesity drug contender, ready to challenge Novo Nordisk and Eli Lilly’s GLP-1 therapies. The company recently…
Read More
GERMANY — Germany’s cabinet has ignited a heated debate by passing a landmark bill that paves the way for legalizing recreational marijuana use and cultivation. If approved by parliament, this…
Read More
GERMANY — Bayer, the prominent German pharmaceutical and pesticides manufacturer has revealed that its downward revision of this year’s earnings forecast was primarily influenced by a less optimistic outlook in…
Read More
GERMANY —Fresenius Kabi, a renowned global healthcare company specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs, has achieved a major milestone with its tocilizumab biosimilar candidate MSB11456.…
Read More